Most Active Stocks Today Tuesday, August 6, 2013 5:12:08 PM

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Most Active Stocks Today Tuesday, August 6, 2013 5:12:08 PM

Symbol - Price  - % Chg - $ Volume - Share Vol - Trades

FNMA 2,667 1.51 -15.64 42,741,205 8,121
FMCC 1,873 1.40 -14.63 20,086,203 4,050
DRIO 21 2.85 -1.72 39,209 34
UBIQ 11 11.4307 +0.97 12,531 51
CLCN 7 1.14 -21.92 17,020 28
LIQT 7 3.00 -0.99 81,011 57
SLNR 7 7.65 +1.59 1,200 3
EVTI 7 3.37 +0.60 1,300 2
UBMI 7 6.00 0.00 8,550 13
FNMAL 5 7.24 -6.58 5,269 12

TLSYY 22.77 +1.20 2,560,884 112,719 144
CMLSW 4.6988 +5.27 2,558,178 540,100 10
BBVXF 9.50 0.00 2,466,100 260,000 2
IGIFF 46.1508 0.00 2,445,992 53,000 1
BGEPF 106.1704 +0.83 2,412,126 22,722 21
DANOY 15.87 +0.44 2,394,180 151,183 149
LVMUY 37.18 +0.08 2,373,939 63,673 132
ONCS 0.34 +3.19 2,340,586 6,668,060 726
VLKAY 46.65 -0.39 2,339,722 50,066 197
YARIY 42.95 -1.85 2,294,875 53,521 71
AAGIY 18.38 -2.55 2,290,057 124,866 124
AFFY 1.58 +5.33 2,244,628 1,405,418 695
FANUY 26.69 +0.41 2,166,968 81,121 168
TOTDY 23.10 +0.92 2,112,041 92,002 16
AZSEY 15.65 -1.26 2,044,424 130,720 208
ADDYY 58.01 +0.02 2,040,885 35,132 57
ANZBY 26.70 +0.26 2,019,106 76,108 116
CICHY 14.49 -1.63 2,005,731 138,504 148
ITYBY 67.56 -0.63 1,941,157 28,739 103
BAESY 27.96 -0.60 1,856,876 66,424 80

BHPLF 31.6165 -0.07 1,849,878 58,466 31
CAKFY 4.34 -2.03 1,846,299 424,333 79
BURBY 48.00 +0.73 1,816,349 37,860 48
HUWHY 23.46 -0.72 1,813,845 77,037 49
SBTB 25.66 -0.35 1,734,454 67,784 54
PUBGY 19.72 +0.72 1,696,205 86,129 74
JGCCY 75.10 +1.09 1,683,468 22,385 40
ZURVY 27.391 -0.14 1,650,275 60,292 143
SGGH 1.41 +12.80 1,639,508 1,241,887 218
SEOAY 7.50 +0.81 1,608,292 214,230 103
DTEGY 12.028 -1.57 1,593,881 132,151 243
BNPQY 32.8156 -0.09 1,581,972 48,227 96
RBGLY 14.52 +1.75 1,567,646 108,106 112
KMTUY 22.20 -1.20 1,565,785 70,561 121
WMMVY 27.24 -0.77 1,545,783 56,927 107
NVIV 4.40 +4.51 1,525,968 366,490 337
HNNMY 7.39 -0.40 1,507,441 203,481 115
LNVGY 19.07 +2.42 1,504,786 78,936 150
RYDAF 32.00 +0.31 1,495,878 46,590 3
CSGKF 29.80 +0.24 1,453,097 48,338 26

BLUF 1.61 -18.50 1,430,931 731,959 743
LQMT 0.191 +1.05 1,424,040 7,506,913 610
AXAHY 22.66 -1.39 1,414,513 62,113 130
RXIID 4.02 +0.50 1,402,432 347,949 68
BAMXY 31.52 -1.28 1,384,235 43,857 84
ASBFY 30.27 +0.03 1,374,558 45,299 21
IFNNY 9.10 0.00 1,359,868 149,004 66
NATDF 9.965 -0.94 1,347,286 134,970 44
SBMRY 49.45 -1.42 1,337,390 27,065 72
FRTSF 30.5761 -0.73 1,333,304 43,600 331
DASTY 134.09 +0.60 1,292,443 9,635 41
CPMK 6.32 +1.12 1,285,344 203,750 10
PPERY 8.35 -2.91 1,266,047 151,609 124
SANB 0.335 -32.24 1,260,787 3,305,464 755
AMAVF 80.00 +2.13 1,208,928 15,097 75
UOVEY 34.18 -1.16 1,183,135 34,712 66
COSWF 19.74 -1.25 1,178,407 60,008 193
PTXKY 8.499 +1.18 1,173,417 138,303 25
KGFHY 12.18 -1.69 1,170,983 95,922 81
SOUL 1.23 +0.82 1,162,442 969,392 536
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 135

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 180

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 235

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

Kulicke & Soffa Announces Conference Call for Fiscal Results

Updated Category News Views 122

Kulicke & Soffa Schedules Conference Call Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC), a leading name in semiconductor assembly technology, has announced a conference call to discuss its third fiscal quarter financial results and business outlook. The call is set for a future date, highlighting the company's commitment to transparency and communication with its...

Continue Reading
ARMOUR Residential REIT Launches Major Stock Offering for Growth

Updated Category News Views 162

ARMOUR Residential REIT Enters Public Stock Offering ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) has officially announced an underwritten public offering of 18,500,000 shares of common stock. The company is poised to grant underwriters an additional option to purchase up to 2,775,000 shares, making this a significant move for ARMOUR as it aims to enhance its...

Continue Reading
Celebrate Mother's Day with a Unique Brunch at Cannon + Belle

Updated Category News Views 195

Cannon + Belle Offers a Memorable Mother's Day Brunch Cannon + Belle at Hilton Austin is excited to announce an elevated Mother's Day brunch that promises to create unforgettable memories. This year, the restaurant will be hosting a special brunch event aimed at honoring mothers and all they do. With an impressive menu curated by the talented Chef Gereamy Cater, guests...

Continue Reading
Figma's Shares Surge in IPO But Valuation Remains a Concern

Updated Category News Views 244

Figma's Impressive IPO Performance Figma Inc. (NYSE: FIG) has captured significant investor attention following its explosive debut in the stock market. After launching its initial public offering, the company's shares skyrocketed by over 250%, marking a remarkable milestone for the firm. The stock began trading at a price of $33 per share, leading to approximately $1.2...

Continue Reading
Journey Medical Corporation's Emrosi Launch for Rosacea Relief

Updated Category News Views 215

Journey Medical Corporation Introduces Emrosi for Rosacea Treatment Journey Medical Corporation, a key player in the dermatological pharmaceutical industry, has recently launched Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules), designed for the effective treatment of rosacea. The product, featuring a unique formulation of 10 mg immediate release and...

Continue Reading